<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1872">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136794</url>
  </required_header>
  <id_info>
    <org_study_id>GUINOT 2021-4</org_study_id>
    <nct_id>NCT05136794</nct_id>
  </id_info>
  <brief_title>LIdocaine veRsus Sufentanil Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypass</brief_title>
  <acronym>LISRACC</acronym>
  <official_title>Opioid Free Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the 90's the concept of morphine sparing and morphine free anaesthesia (OFA) has&#xD;
      progressively developed in non-cardiac surgery. The principle is based on the fact that in a&#xD;
      sleeping patient a sympathetic reaction marked by hemodynamic modifications does not&#xD;
      translate into a painful phenomenon, that a painful phenomenon in a sleeping patient is not&#xD;
      memorized, that hormonal stress, the sympathetic reaction and the inflammatory reaction can&#xD;
      be controlled by other therapeutic classes than a morphine agent. This therapeutic management&#xD;
      would avoid the side effects associated with the use of morphine. In this hypothesis, OFA is&#xD;
      more and more practiced in various situations without the real impact in terms of clinical&#xD;
      benefit being clearly demonstrated. In cardiac surgery, some centers practice OFA with&#xD;
      various protocols.The purpose of this work is to retrospectively evaluate over a defined&#xD;
      period the incidence of postoperative complications, length of stay in the ICU/hospital, and&#xD;
      death rate between patients managed with/without OFA based on lidocaine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ICU stays (days)</measure>
    <time_frame>Day 30</time_frame>
    <description>Total stay in ICU in day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Day 30</time_frame>
    <description>cardiac, neurological, renal, respiratory, red blood transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stays (days)</measure>
    <time_frame>Day 30</time_frame>
    <description>hospital stay</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Opioid Free Anaesthesia</condition>
  <condition>Opioid Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Opioid free anaesthesia</arm_group_label>
    <description>patient anesthtesized with lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid anaesthesia</arm_group_label>
    <description>patients anesthetized with sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>complications: cardiac, neurological, renal, respiratory, red blood transfusion Hospital stays: ICU stays and hospital stay</description>
    <arm_group_label>Opioid anaesthesia</arm_group_label>
    <arm_group_label>Opioid free anaesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac surgical&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        age over 18 years Cardiac surgery with cardiopulmonary bypass performed between January&#xD;
        2019 and June 2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        LVAD Heart transplantation Incomplete data in relation to outcomes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre-Grégoire Guinot</last_name>
    <phone>03.80.28.13. 09</phone>
    <email>guinotpierregregoire@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pierre-Grégoire GUINOT</last_name>
      <phone>03.80.28.13. 09</phone>
      <email>guinotpierregregoire@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 16, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

